David Burdette, MD
Epilepsy · Grand Rapids, MINPI 1679648315
Payments from drug & device makers
Across 1,637 payments — averaging $890.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$615K
- Jazz Pharmaceuticals Inc.$240K
- Neuropace, Inc.$193K
- SK Life Science, Inc.$180K
- Greenwich Biosciences, Inc.$93K
- Eisai Inc.$73K
- plus $62K from 16 others
Across 803 payments — averaging $473.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neuropace, Inc.$380K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 798 | $615,384 |
| Jazz Pharmaceuticals Inc. | 207 | $240,199 |
| Neuropace, Inc. | 261 | $193,452 |
| SK Life Science, Inc. | 186 | $179,866 |
| Greenwich Biosciences, Inc. | 87 | $93,250 |
| Eisai Inc. | 44 | $73,299 |
| UCB SA | 8 | $36,504 |
| Catalyst Pharmaceuticals, Inc. | 14 | $12,031 |
| Zogenix Inc. | 3 | $6,850 |
| H. Lundbeck A S | 9 | $2,675 |
| Sunovion Pharmaceuticals Inc. | 2 | $2,572 |
| Livanova USA, Inc. | 3 | $778 |
| Neurelis, Inc. | 5 | $337 |
| Orthofix Medical, Inc. | 1 | $134 |
| Aquestive Therapeutics, Inc. | 1 | $125 |
| Medtronic | 2 | $43 |
| Upsher-smith Laboratories LLC | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $28 |
| Zimmer Biomet | 1 | $25 |
| Otter Pharmaceuticals, LLC | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,457,629 in reported general payments places this provider in the 95th percentile of 30 epilepsy providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other epilepsy in Grand Rapids
- Evan TankGrand Rapids$28K
- Ammar KhederGrand Rapids$23K
- Charles AsburyGrand Rapids$2K
- Rachel FabrisGrand Rapids$2K
- David OrtizGrand Rapids$2K
- Philip McCarthyGrand Rapids$1K
- Luke SalbertGrand Rapids$962
- Desiree MarkantoneGrand Rapids$431
- Shan AbbasGrand Rapids$298
- Erin OkazakiGrand Rapids$260
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.